Beta-cell therapies for type 1 diabetes: Transplants and bionics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30526754.
- Also identified by DOI 10.3949/ccjm.85a.17088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Research continues toward the goal of treating type 1 diabetes by replacing insulin-producing beta cells. Ideally, such treatment would be safe and long-lasting and would eliminate the need for subcutaneous insulin replacement. This article reviews the current state of beta-cell replacement through transplant of the whole pancreas or of islet cells. It also looks at the "bionic" pancreas and other future challenges.
Medical subject headings
- Bionics
- Diabetes Mellitus, Type 1
- Insulin-Secreting Cells
- Islets of Langerhans Transplantation
- Pancreas Transplantation